Showing results (41-50 of 511) with videos related to
Sort By:
Pageof 52
Current Opinion in Oncology|February 19, 2021
Understanding the tumor-immune microenvironment in prostate cancerLiang Dong, Kayla V Myers, Kenneth J PientaNeoplasia (New York, N.Y.)|December 19, 2009
CCL2 is a negative regulator of AMP-activated protein kinase to sustain mTOR complex-1 activation, survivin expression, and cell survival in human prostate cancer PC3 cellsHernan Roca, Zachary S Varsos, Kenneth J PientaOncology (Williston Park, N.Y.)|December 3, 1999
Pain management in patients with advanced prostate cancerKarin B Olson Pa-C, Kenneth J PientaProceedings of the National Academy of Sciences of the United States of America|August 30, 2006
Evolution of cooperation among tumor cellsRobert Axelrod, David E Axelrod, Kenneth J PientaJournal of Cellular Biochemistry|March 3, 2004
Dynamic process of prostate cancer metastasis to boneKwanchanit Tantivejkul, Linda M Kalikin, Kenneth J PientaClinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2011
Hematopoietic stem cell niche is a potential therapeutic target for bone metastatic tumorsYusuke Shiozawa, Kenneth J Pienta, Russell S TaichmanUrology Case Reports|January 27, 2025
Incidental discovery of gastrointestinal stromal tumor via PSMA-PET/CT imaging: Insights from a case reportVenetia A Florou, Diane K Reyes, Kenneth J PientaCancer Metastasis Reviews|November 21, 2024
Bystanders or active players: the role of extra centrosomes as signaling hubsMadison M Purkerson, Sarah R Amend, Kenneth J PientaPET Clinics|September 24, 2022
Prostate-Specific Membrane Antigen-Based PET Brings New Insights into the Management of Prostate CancerCong Hu, Liang Dong, Wei Xue, et al.Urology|September 6, 2005
Osteonecrosis of jaw in patient with hormone-refractory prostate cancer treated with zoledronic acidKarin B Olson, C Michael Hellie, Kenneth J PientaPageof 52